IndraLab

Statements


CASP8 methylates CDKN2A. 1 / 1
| 1

reach
"Promoter methylation status : CASP8 : in 36/40 tumors methylated; TIMP3 : 1/38 methylated; MGMT 0/44 methylated; CDKN2A : 1/46 methylated; E-cadherin 3/36 methylated; no association between methylation status and clinical outcome."